Research published on Nutrition21's esports nootropic

11-Nov-2021

The double blind, randomised, placebo controlled, crossover trial was conducted in 26 male and female experienced gamers

Research on the cognitive benefits of Nutrition21's nooLVL, a patented complex of bonded arginine silicate with an additional dose of Inositol, has been published in Nutrients. The study, done at Texas A&M University, demonstrated a single dose of the complex increases cognitive performance within 15 minutes.

The double blind, randomised, placebo controlled, crossover trial was conducted in 26 male and female experienced gamers who were randomly assigned to consume 1600 mg of nooLVL or 1600 mg of a placebo (PLA).

During testing sessions, participants completed stimulant sensitivity questionnaires and performed a variety of cognitive function tests. Fifteen minutes following ingestion, participants repeated these tests (pre-game) and then played their favourite video game for 1 hour and repeated the battery of tests (post-game). Study subjects observed a 7 to 14-day washout period and then replicated the study with the alternative treatment. Results showed supplementation enhanced short-term and working memory, reaction time and concentration.

The data supports prior research on the ingredient's cognitive benefits, the company says, for esports gamers, who rely on quick reactions, focus, memory, and fine motor skills to excel during competition.

Sign up for your free email newsletter

“This is our second study on nooLVL showing a range of cognitive performance benefits specifically in gamers. This is exciting for Nutrition21 since we were the first to study cognitive function in egamers,” said Danielle Greenberg, FACN, VP, Scientific Affairs, Nutrition21. “This latest research allows us to add new cognitive performance claims around short-term and working memory, as well as reinforce the reaction time claims from our first study.”

Companies